Purpose: This study aims to observe the effects of notopterol on the apoptosis and differentiation of HL-60 cells and to explore the underlying molecular mechanisms. Methods: Cell viability was assessed using sulforhodamine B assay. Cell proliferation was determined by the trypan blue dye exclusion test. Colony-forming units were assayed in methylcellulose. Apoptosis assays were carried out by annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) double staining, Hoechst 33342 staining, mitochondrial membrane potential, and Western blot. Wright-Giemsa staining, nitroblue tetrazolium (NBT) reduction assay, CD11b and CD14 and Western blot were detected for induction of differentiation. In addition, cell-cycle phase distribution was analyzed by flow cytometry and Western blot. The combination therapy of notopterol and all-trans retinoic acid (ATRA) on HL-60 cells was examined. Results: Notopterol obviously inhibited the growth of HL-60 cells with an IC 50 value of 40.32 μM and remarkably reduced the number of colonies by 10, 20, and 40 µM. In addtion, notopterol induced the percentage of apoptotic HL-60 cells, reduced the mitochondrial membrane potential, decreased the protein expresstion of Bcl-2 and Mcl-1, and increased the expression of Bax, cleavage of caspase 9, caspase 3, and PARP. As for cell differentiation, notopterol clearly induced chromatin condensation; increased the nucleocytoplasmic ratio, nitroblue tetrazolium-positive cells, expression of CD14 and CD11b, and protein expression of c-Jun and Jun B, and decreased c-myc. Furthermore, notopterol induced the G0/G1 cell-cycle arrest as determined using flow cytometry, which may be related to the regulation of cell-cycle-related proteins p53, CDK2, CDK4, Cyclin D1, Cyclin E, and survivin. The combined use of notopterol and ATRA did not enhance the apoptotic effect as evidenced by cell viability test and Hoechst 33342. However, the combination of notopterol and ATRA enhanced the effect of inducing differentiation when compared with using either notopterol or ATRA alone, which can be evidenced by the increased nucleocytoplasmic ratio, NBT positive cells, and expression of CD14. Conclusion: This is the first time it has been demonstrated that notopterol could induce apoptosis, differentiation, and G0/G1 arrest in human AML HL-60 cells, suggesting that notopterol has potential therapeutic effects on AML. The combination application of notopterol (20 and 40 μM) and ATRA (2 μM) could augment differentiation of HL-60 cells.
Introduction
Leukemia is a heterogeneous clonal disorder of hemopoietic progenitor cells, which is characterized by abnormal proliferation, clonality and differentiation. 1, 2 In 2018, there is expected to be 19,520 new cases of acute myeloid leukemia (AML), and 10,670 people died of it. 3 At present, the main treatment strategy for leukemia is chemotherapy. In the past 30 years, refinement of supportive treatment has improved the outlook of patients with AML. However, more than half of the young adults and about 90% of the older patients still die of AML. 4 Therefore, it is urgent to find other therapeutic strategies for AML treatment. Notopterygium incisum Ting ex H. T. Chang (N. incisum), known as Qianghuo, is commonly used to treat rheumatism and injury in traditional Chinese medicine. Modern pharmacological studies have confirmed that N. incisum has effects of antipyretic, analgesic, anti-inflammatory, antiviral, anticancer, etc. 5, 6 Notopterol, one type of coumarin, is an active monomer extracted from N. incisum with antipyretic, analgesic and anti-inflammatory effects, which also has been reported to induce cell-cycle-specific inhibition and apoptosis in MCF-7 cancer cell line. 5, [7] [8] [9] However, there is no report about its effect on leukemia.
Multiple mechanisms of apoptosis are involved in the treatment of cancer, among which the mitochondrial intrinsic apoptotic pathway plays the most pivotal role. Importantly, induced apoptosis by regulating Bcl-2 family members has a major role in the treatment of many drugs on AML. 10, 11 Recently, tumor differentiation therapy has become a hot spot as all-trans retinoic acid (ATRA) is used in the treatment of AML for inducing differentiation of cancer cells, which has advantages of high efficacy and low toxicity and side effects. 12 Cell-cycle proteins are considered as effective targets in cancer therapy. 13 Multiple drugs could inhibit HL-60 cells by regulating the expression of cell-cycle proteins and inducing cell-cycle arrest. 14, 15 In this study, we first characterized the inhibitory effect of notopterol on HL-60 cells which belong to human leukemia cell line that have been used for laboratory research on blood cell formation and physiology. On the one hand, cell viability, proliferation and colony formation assay were performed to determine whether notopterol induces death in HL-60 cells. On the other hand, we explored the mechanism of notopterol-inducing apoptosis by detection of mitochondrial intrinsic apoptotic pathway. Then, we characterized the effect of notopterol on differentiation and cell-cycle arrest of HL-60 cells. We examined the phenotype changes in differentiation, proteins associated with differentiation and cell cycle. In addition, combination therapy of notopterol and ATRA was used to test whether they had beneficial effect on HL-60 cells. Our findings may provide basis for application of notopterol and provide candidate drug for treatment of AML. 
Materials and methods

Chemicals and antibodies
Measurement of cell viability
The cell viability of notopterol was determined by sulforhodamine B (SRB) assay. 
Nitroblue tetrazolium (NBT) reduction assay
Western blotting analysis
For protein analysis of Bcl-2 family members, caspases, Jun B, c-Jun, protein p53, c-myc, CDK2, CDK4, CyclinD1, CyclinE, survivin and PARP, cells (2×10 5 cells/mL) were treated with vehicle or different concentrations of notopterol for 48 hrs. Harvested cells were washed with ice-cold PBS for 3 times. RIPA lysis buffer (Cell Signaling Technologies) containing protease inhibitor (Thermo Fisher Scientific, Waltham, MA, US) phenylmethanesulfonyl fluoride (Multi Sciences, Hangzhou, China) was used to extract total protein for 10 mins at 4°C. The supernatant was transferred to another new Eppendorf tube. The protein samples were then separated on 10-15% SDS-PAGE and transferred to polyvinylidene fluoride membrane. The membranes were blocked for 2 hrs in 5% BSA (Sangon Biotech, Shanghai, China) at room temperature, and then incubated with the primary antibodies overnight at 4°C. After incubation, the membranes were washed with Trisbuffered saline containing Tween-20 (TBST). The membranes were then incubated with goat anti-rabbit or goat anti-mouse secondary antibodies for 2 hrs at room temperature. After washing with TBST three times for 10 mins, the immunoreactive complexes were visualized by enhanced chemiluminescence (ECL) detection reagent (GE Healthcare, Uppsala, Sweden). The protein levels were first normalized to β-actin or GAPDH and then normalized to control.
Statistical analysis
Data were expressed as the Mean ± SD. The statistical signifiance of the differences was determined using Student's t-test or one-way ANOVA in SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA 
Results
Notopterol inhibited cell growth of HL-60 cells
To determine the inhibitory effect of notopterol on HL-60, Kasumi-1 and U937 cell growth, we first used SRB assay to evaluate the cell viability. As shown in Figure 1A , notopterol showed greater inhibitory effect on HL-60 cells than Kasumi-1 and U937 with IC 50 value of 40.32, 56.68 and 50.69 μM, respectively. Therefore, we chose HL-60 cells for further study. The influence of notopterol on the proliferation of HL-60 cells was determined. Figure 1B showed that 10-80 μM of notopterol inhibited the proliferation of HL-60 cells in a concentration-dependent manner within 120 hrs. HL-60 cells treated with 10, 20 and 40 μM notopterol for 120 hrs presented with significantly reduced cell numbers compared with controls. Notably, 60 and 80 μM of notopterol almost totally suppressed the proliferation of HL-60 cells (P<0.01). To evaluate the inhibitory effect on cell proliferation with a long-term treatment of notopterol, the methylcellulose-based colony formation assay was performed. It can be seen from Figure 1C that the size of colonies decreased in a concentration-dependent manner after HL-60 cells were treated by notopterol (5-40 µM) for 2 weeks. In addition, similar to cell viability results, cells that were treated with notopterol formed less colonies compared with the control group. Quantification results showed that there was 25%, 30%, 60% and 70% decrease in colonies formed with 5 (P<0.05), 10 (P<0.01), 20 (P<0.01) and 40 (P<0.01) µM of notopterol. In summary, the above mentioned results consistently suggest that notopterol exhibits a negative effect on cell survival, proliferation and growth.
Notopterol-induced apoptosis of HL-60 cells
To characterize the effect of notopterol on cell death of HL-60 cells, we first examined the apoptosis rate of cells treated with notopterol by annexin V-FITC and PI staining by flow cytometry analysis. As shown in Figure 2A , flow cytometry analysis showed that notopterol promoted cell apoptosis in a dose-dependent manner. Figure 2B that the proportion of cells with nuclear fragmentation and condensation was obviously increased after notopterol treatment. These data suggest that notopterol induces cell apoptosis.
Notopterol-induced apoptosis is mediated by activation of the mitochondrial intrinsic apoptotic pathway
To further explore the underlying mechanism of apoptosis induced by notopterol, we first examined whether notopterol induces apoptosis through the mitochondrial intrinsic apoptotic pathway by immunofluorescence staining. Mitochondrial membrane potential was examined by staining with JC-1, a lipophilic, cationic dye that exhibits a fluorescence emission shift upon aggregation from 530 nm (green) to 590 nm (red). In normal cells with a high mitochondrial membrane potential, JC-1 enters the mitochondrial matrix in a potential-dependent manner and forms aggregates. However, in apoptotic cells, mitochondrial transmembrane potential depolarizes, then JC-1 was released from the mitochondria. Consequently, it reverses to a monomeric form that emits green fluorescence. As shown in Figure 3A , there was a significant increase in green fluorescence and decrease in red fluorescence in the cells exposed to notopterol (5-60 µM) when compared with control, indicating collapse of mitochondrial membrane. Then, we examined the expression levels of proteins associated with mitochondrial intrinsic apoptotic pathway, including Bcl-2, Bax, caspase-3 and −9, PARP and Mcl-1. As shown in Figure 3B , notopterol increased the expression of Bax and decreased the expression of 
Bcl-2 and Mcl-1 in HL-60 cells after 48-hr treatment.
Moreover, notopterol also promoted the cleavage of caspase 9, caspase 3 and PARP. Taking these results into account, we hypothesize that mitochondria plays a role in notopterol-induced apoptosis.
Notopterol-induced differentiation of HL-60 cells
To examine the effect of notopterol on the differentiation of HL-60 cells, we first detected the morphologic changes of cells treated with notopterol by WrightGiemsa staining. As shown in Figure 4A , notopterol (10, 20 and 40 µM) clearly induced the chromatin condensation and increased the nucleocytoplasmic ratio in HL-60 cells. Then, the NBT assay was performed to detect the production of oxidative bursts during the cell differentiation ( Figure 4B ). NBTpositive cells were concentration-dependently increased after treated by notopterol (5 to 40 µM) ( Figure 4B ). To further characterize the differentiation mediated by Notopterol induces G0/G1 phase arrest associated with cell-cycle proteins in HL-60 cells
To further explore whether the inhibitory effect of notopterol on HL-60 cells is due to its induction of cell-cycle arrest, highresolution flow cytometry analysis of PI-stained nuclei was performed. As shown in Figure 6A , when compared with control group, the exposure of HL-60 cells to notopterol remarkably resulted in the accumulation of cells in G1 phase from 25.67±3.77 to 31.76±1.24, 35.44±4.09, 44.50±6.91 and 51.99±3.64 at 0, 5, 10 (P<0.05), 20 (P<0.05), 40 (P<0.01) µM, respectively. Furthermore, the protein expression levels of the molecules involved in the G0/G1-phase arrest were analyzed by western blot. As shown in Figure 6B , the expression levels of CDK2, CDK4, CyclinD1, CyclinE and survivin were decreased in a concentration-dependent manner with elevated p53 expression. These results demonstrate that notopterol inhibits the growth of HL-60 cells probably via arresting inducing G0/G1 phase arrest.
The effect of combination therapy notopterol and ATRA on HL-60 cells death. As shown in Figure 7A , notopterol can dosedependently inhibited the cell viability of HL-60 (P<0.01). 1 and 2 μM of ATRA-treated cells were inhibited (P<0.01). However, the combined use of notopterol and ATRA did not enhance this inhibition.
In Figure 7B , 20 or 40 μM of notopterol could increase the apoptotic rate, while 2 μM of ATRA did not induce apoptotis of HL-60. Likewise, the combination of notopterol and ATRA did not enhance the apoptotic effect. Altogether, we can draw a preliminary conclusion that the combination of notopterol and ATRA(1, 2 μM) has no synergistic effect on apoptosis and viability of HL-60 cells. Then, we tested its effect on differentiation. In Figure 8A , notopterol (20, 40 μM), ATRA (1 μM) could induce the chromatin condensation and increased the nucleocytoplasmic ratio separately. The combination of these two drugs (40 μM notopterol +1 μM ATRA, P<0.01) could obviously enhance the effect when compared with using either ATRA or notopterol alone. Moreover, in Figure 8B , the combination use (40 μM notopterol + 1 μM ATRA, P<0.01) also increased the NBT-positive cells, as compared with ATRA alone. In addition, according to previous study, we detected the expression of cell surface maker CD14 ( Figure 8C ). It showed the combination application (40 μM notopterol +1 μM ATRA, P< 0.01) enhanced the expression level of CD14, as compared with notopterol or ATRA alone. Therefore, the above results can indicate the combination of notopterol and ATRA has synergistic effect on differentiation of HL-60 cells. 
Discussion
At present, although chemotherapy is the most commonly used treatment, it also kills normal cells, causing many side effects. Therefore, it is urgent to develop novel alternative therapeutic strategies to overcome these problems. Studies showed notopterol, a main component existing in N. incisum, had antipyretic, analgesic and antiinflammatory effects; however, there no reports about its effect on AML, let alone its application in clinics. In our preliminary investigation, through screening the active ingredients of traditional Chinese medicine, it was found that notopterol remarkably induced cell death of HL-60 cells U937, and Kasumi-1 cells. Interestingly, the inhibitory effect of notopterol on HL-60 cells was stronger than 24, 25 For G1 phase to S phase transition, all cells must activate CDK4/6, which combines with CyclinD1. CDK4/6 neutralizes p27Kip1 and induces E2F-dependent transcription of cyclins, resulting in the activation of CDK2, consequently let cells enter into S phase. CDK2 combines with Cyclin (E1, E2) and Cyclin A, which can be suppressed by p53. 26, 27 The expressions of CDK2, CDK4, CyclinD1
and CyclinE were decreased with the increasing expression of p53 following notopterol treatment. Overexpression of survivin leads to an increase in S phase, which protects cells from G1 phase blockade, eventually leading to the activation of CDK2/Cyclin E complex. 28 Our results found that the expression of survivin was also repressed by notopterol. ATRA together with chemotherapy used as the first-line treatment for the newly diagnosed acute promyelocytic leukemia (APL) patients. However, APL patients treated with ATRA alone easily relapse. Nowadays, efforts have focused on the search of agents that can enhance ATRA's effect on AML cells. Our results suggested that combination of notopterol and ATRA could not increase cell death. Interestingly, inducing differentiation effect was obviously enhanced when cells were treated with both notopterol and ATRA as evidenced by increasing nucleocytoplasmic ratio, NBT-positive cells and expression level of CD14.
Conclusion
In summary, we found notopterol effectively inhibited the proliferation, promoted the apoptosis and induced the differentiation and G0/G1 arrest in HL-60 cells. To the best of our knowledge, this is the first study to reveal that notopterol has the inhibitory effect on HL-60 cells, which could provide a basis to further evaluate the potential applications of notopterol as a promising drug for the treatment of AML. Moreover, combination therapy of notopterol and ATRA is worth for further research.
Consent for publication
All authors have provided consent for publication.
